Thank you for the invitation IASLC ! Promising results for #BRAF-mutant lung cancer, yet much to be done re. - Therapy sequence (ICI vs targeted therapy) - Resistance to therapy We work on some of these challenges in the #BOLEROConsortium #LCAM23 #LCSM CRCL Centre Leon Berard